These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14609169)

  • 1. Prognostic significance of annexin VII expression in glioblastomas multiforme in humans.
    Hung KS; Howng SL
    J Neurosurg; 2003 Nov; 99(5):886-92. PubMed ID: 14609169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
    Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
    Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic relevance of p53 protein expression in glioblastoma.
    Birner P; Piribauer M; Fischer I; Gatterbauer B; Marosi C; Ungersböck K; Rössler K; Budka H; Hainfellner JA
    Oncol Rep; 2002; 9(4):703-7. PubMed ID: 12066196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical and pathological significance of p53 gene mutation in human cerebral glioblastoma multiforme].
    Matsumoto R
    Hokkaido Igaku Zasshi; 1998 Jul; 73(4):407-17. PubMed ID: 9828926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of ANX7-GTPase in metastatic and HER2-negative breast cancer patients.
    Srivastava M; Bubendorf L; Raffeld M; Bucher C; Torhorst J; Sauter G; Olsen C; Kallioniemi OP; Eidelman O; Pollard HB
    Clin Cancer Res; 2004 Apr; 10(7):2344-50. PubMed ID: 15073110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas.
    Bouvier-Labit C; Chinot O; Ochi C; Gambarelli D; Dufour H; Figarella-Branger D
    Neuropathol Appl Neurobiol; 1998 Oct; 24(5):381-8. PubMed ID: 9821169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of homozygous deletion of the p16 gene and correlation with survival in patients with glioblastoma multiforme.
    Kamiryo T; Tada K; Shiraishi S; Shinojima N; Nakamura H; Kochi M; Kuratsu J; Saya H; Ushio Y
    J Neurosurg; 2002 May; 96(5):815-22. PubMed ID: 12005388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
    Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
    J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Worse outcome in primary glioblastoma multiforme with concurrent epidermal growth factor receptor and p53 alteration.
    Ruano Y; Ribalta T; de Lope AR; Campos-Martín Y; Fiaño C; Pérez-Magán E; Hernández-Moneo JL; Mollejo M; Meléndez B
    Am J Clin Pathol; 2009 Feb; 131(2):257-63. PubMed ID: 19141386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related expression of p53, Mdm2, EGFR and Msh2 in glioblastoma multiforme.
    Stark AM; Hugo HH; Witzel P; Mihajlovic Z; Mehdorn HM
    Zentralbl Neurochir; 2003; 64(1):30-6. PubMed ID: 12582944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ANX7, a candidate tumor suppressor gene for prostate cancer.
    Srivastava M; Bubendorf L; Srikantan V; Fossom L; Nolan L; Glasman M; Leighton X; Fehrle W; Pittaluga S; Raffeld M; Koivisto P; Willi N; Gasser TC; Kononen J; Sauter G; Kallioniemi OP; Srivastava S; Pollard HB
    Proc Natl Acad Sci U S A; 2001 Apr; 98(8):4575-80. PubMed ID: 11287641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monosomy of chromosome 10 associated with dysregulation of epidermal growth factor signaling in glioblastomas.
    Yadav AK; Renfrow JJ; Scholtens DM; Xie H; Duran GE; Bredel C; Vogel H; Chandler JP; Chakravarti A; Robe PA; Das S; Scheck AC; Kessler JA; Soares MB; Sikic BI; Harsh GR; Bredel M
    JAMA; 2009 Jul; 302(3):276-89. PubMed ID: 19602687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can MRI-derived factors predict the survival in glioblastoma patients treated with postoperative chemoradiation therapy?
    Nakamura H; Murakami R; Hirai T; Kitajima M; Yamashita Y
    Acta Radiol; 2013 Mar; 54(2):214-20. PubMed ID: 23138021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors influencing clinical outcomes of malignant glioblastoma multiforme: clinical, immunophenotypic, and fluorescence in situ hybridization findings for 1p19q in 816 chinese cases.
    Qin JJ; Liu ZX; Wang JM; Du J; Xu L; Zeng C; Han W; Li ZD; Xie J; Li GL
    Asian Pac J Cancer Prev; 2015; 16(3):971-7. PubMed ID: 25735391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-guided resection of glioblastoma multiforme by using 5-aminolevulinic acid-induced porphyrins: a prospective study in 52 consecutive patients.
    Stummer W; Novotny A; Stepp H; Goetz C; Bise K; Reulen HJ
    J Neurosurg; 2000 Dec; 93(6):1003-13. PubMed ID: 11117842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype.
    Choe G; Park JK; Jouben-Steele L; Kremen TJ; Liau LM; Vinters HV; Cloughesy TF; Mischel PS
    Clin Cancer Res; 2002 Sep; 8(9):2894-901. PubMed ID: 12231534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors influencing clinical outcomes of glioblastoma multiforme.
    Li SW; Qiu XG; Chen BS; Zhang W; Ren H; Wang ZC; Jiang T
    Chin Med J (Engl); 2009 Jun; 122(11):1245-9. PubMed ID: 19567131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological findings and prognostic factors in recurrent glioblastomas.
    Okita Y; Narita Y; Miyakita Y; Ohno M; Fukushima S; Kayama T; Shibui S
    Brain Tumor Pathol; 2012 Oct; 29(4):192-200. PubMed ID: 22331317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.